MedPath

Effect of Garudan Kizhangu Ennai and Keedari Thailam for Puzhuvettu (Alopecia Areata) in childre

Phase 3
Completed
Conditions
Health Condition 1: L639- Alopecia areata, unspecified
Registration Number
CTRI/2022/07/043741
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1.Hair loss in patches.

2.Non-scarring.

3.Scattered long hairs within the bald area.

4.Willing to take photographs whenever required.

5.Patients who are willing to stay in IPD Ward or willing to attend OP Dept. as per schedule.

6.Patient’s informant / Parent willing to sign the informed consent.

Exclusion Criteria

1.Scarring alopecia

2.Alopecia universalis

3.Alopecia totalis

4.Vitiligo

5.Atopic dermatitis

6.Tinea capitis

7.Trichotillomania

8.Any other serious illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness of the trial drug is measured by Severity of Alopecia Tool (SALT) Score.Timepoint: 45 days
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath